Syneos Health, Inc. - (SYNH) News

Syneos Health, Inc. - (SYNH): $42.98

0.01 (+0.02%)

POWR Rating

Component Grades








Filter SYNH News Items

SYNH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SYNH News Highlights

  • SYNH's 30 day story count now stands at 7.
  • Over the past 22 days, the trend for SYNH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about SYNH are AC, CIVI and HAYW.

Latest SYNH News From Around the Web

Below are the latest news stories about SYNEOS HEALTH INC that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Syneos Health Closes Transaction with Private Investment Firms

Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma CustomersMORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas

Yahoo | September 28, 2023

Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600

S&P SmallCap 600 constituent Civitas Resources Inc. (NYSE: CIVI) will replace Syneos Health Inc. (NASD: SYNH) in the S&P MidCap 400, and Hayward Holdings Inc. (NYSE: HAYW) will replace Civitas Resources in the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 29. Elliot Investment Management is acquiring Syneos Health in a deal expected to be completed soon pending final conditions.

Yahoo | September 26, 2023

Syneos Health Names Terttu Haring President, Clinical Sites & Patients

Industry Veteran to Play Critical Role in Leading Global Clinical Operations, Cultivating Site Relationships, Empowering Patients and Shaping Innovative Clinical Trial SolutionsMORRISVILLE, N.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, has announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients. With nearly 30 years of experience, Dr. Haring will lead the global clinical

Yahoo | September 26, 2023

Syneos Health (SYNH) Declares Strategic Partnership With Oracle

Syneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities.

Yahoo | September 13, 2023

Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity

MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup solutions, the companies seek to help reduce the time it takes to recruit patients for clinical studies and increase the diversity of patient populations pa

Yahoo | September 12, 2023

Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

While Syneos Health, Inc. ( NASDAQ:SYNH ) might not be the most widely known stock at the moment, it maintained its...

Yahoo | September 7, 2023

Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured Notes

MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the “Issuer” or the “Company”) and Syneos Health, Inc. (“Syneos Health”), announced today that, subject to market conditions and other factors, the Issuer intends to offer $1,700,000,000 aggregate principal amount of Senior Secured Notes due 2030 (the “Notes”). The Issuer intends to use the proceeds from the offering together with other financing sources to fund the previously announced acquisition of Syneos Health (the “Ac

Yahoo | September 6, 2023

Syneos Health (SYNH) Expands Catalyst Site Program to China

Syneos Health (SYNH) announces a collaboration with China's Wuhan Union Hospital, expanding clinical trial capabilities.

Yahoo | August 28, 2023

BB Stock Alert: Is Veritas Capital About to Takeover Blackberry?

Blackberry (BB) stock jumped a surprise 18% today on rumors that private equity firm Veritas is considering a takeover of the company.

Shrey Dua on InvestorPlace | August 25, 2023

Syneos Health (SYNH) to Go Private, Reports Q2 Performance

Syneos Health (SYNH) announces shareholders' approval for the impending merger and releases second-quarter 2023 financial results.

Yahoo | August 11, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!